SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SAFESKIN

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: agent99 who wrote (386)10/29/1998 11:44:00 AM
From: Beltropolis Boy  Read Replies (1) of 828
 
Safeskin Corp. Cut to 'Neutral' at Salomon Smith Barney.

in all this confusion, i lost my head and combed the yahoo 'boreds.' highlights, so to speak, below.

if you're going long today, be sure to call and thank melissa (and SSB) a year from now. they're right behind me in the kmart checkout line buying on the cheap.

-----

#1279: "Salomon Smith Barney downgrades from buy (1) to NEUTRAL (3). Sighting 5% qtq sales growth but 61% increase in Acc Rec as well as high inventories at distribution levels."

#1283: "My source at SSB told me that the neutral rating was forced on the analyst by the head of research - the analyst initially was going to bring it down to a 2 rating. All this negative sentiment is really overdone - salesforce sees no slowing of demand from customers or distributors, so acc rec and inventory issues should ease significantly in Q4."

#1292: "I just spoke to my broker at SS Barney, and he said that the analyst there have a disliking to their fundimentals [sic]. Even though the numbers were great, they fear the 4th quarter."
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext